Insiders who reported open-market trades in the last 12 months at the companies Gilla Kaplan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Gilla Kaplan is a corporate insider of Avalo Therapeutics, Inc. (AVTX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Gilla Kaplan last file a Form 4?
The most recent primary Form 4 on record is dated 4 June 2026, one of 8 filings going back to 2025.
Has Gilla Kaplan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($1.16M) across all tracked filings.
Gilla Kaplan files SEC Form 4 reports at Avalo Therapeutics, Inc. (AVTX). 8 SEC Form 4 filings on record going back to 2025, most recently on 4 June 2026. Most recent open-market trade: sold $529K of TYRA on 27 March 2026. Lifetime open-market sales: $1.16M.
Recent transactions
11
The latest 11 SEC Form 4 transactions reported by Gilla Kaplan.
InsiderAlpha's records for Gilla Kaplan go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
